Searle Licenses Beximco’s Remdesivir For Pakistan

Version Of Gilead’s Potential COVID-19 Treatment Already Launched In Bangladesh

 
• By David Wallace
  
Bangladesh_Pakistan
Searle has licensed the drug for Pakistan from Bangladesh’s Beximco • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business